Читать книгу Clinical Pharmacology and Therapeutics - Группа авторов - Страница 143

Cost‐minimisation analysis (CMA) is the simplest form of economic evaluation. It is used where two or more treatments are known to have exactly the same outcomes, for example, in terms of proportion of patients successfully treated. The analysis is therefore simply reduced to a search for the least costly treatment. An example would be where a clinical trial had shown two antibiotic drugs to be equally effective in clearing an infection. The CMA would then simply compare the costs of the two treatments and the preferred treatment would be the lower cost alternative. The cost differences would include not only the drug acquisition costs but also any costs involved in drug administration, drug monitoring or management of adverse drug reactions.